When the Price of (FBRX) Talks, People Listen

Stock Information for Forte Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Forte Biosciences Inc.

Forte Biosciences Announces Pricing of $75 Million Public Offering
Forte Biosciences Announces Proposed Public Offering
Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study
Forte Biosciences, Inc. Announces Results and Provides Update
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
Forte Biosciences to Host R&D Day December 3, 2024
Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.